Kwei-Nsoro Robert, Attar Bashar, Shaka Hafeez, Ojemolon Pius, Sana Muhammad, Shaka Abdul Tawab, Baskaran Naveen, Kanemo Philip, Doraiswamy Mohankumar
Department of Internal Medicine, John H Stroger Jr Hospital of Cook County, Chicago, IL, USA.
Division of Gastroenterology and Hepatology, John H Stroger Jr Hospital of Cook County, Chicago, IL, USA.
Gastroenterology Res. 2023 Jun;16(3):157-164. doi: 10.14740/gr1623. Epub 2023 Jun 11.
The coronavirus disease 2019 (COVID-19) pandemic led to significant mortality and morbidity in the United States. The burden of COVID-19 was not limited to the respiratory tract alone but had significant extrapulmonary manifestations. We decided to examine the causes, predictors, and outcomes of gastrointestinal (GI)-related causes of 30-day readmission following index COVID-19 hospitalization.
We used the National Readmission Database (NRD) from 2020 to identify hospitalizations among adults with principal diagnosis of COVID-19. We identified GI-related hospitalizations within 30 days of index admission after excluding elective and traumatic admissions. We identified the top causes of GI-related readmission, and the outcomes of these hospitalizations. We used a multivariate Cox regression analysis to identify the independent predictors of readmission.
Among 1,024,492 index hospitalizations with a primary diagnosis of COVID-19 in the 2020 NRD database, 644,903 were included in the 30-day readmission study. Of these 3,276 (0.5%) were readmitted in 30 days due to primary GI causes. The top five causes of readmissions we identified in this study were GI bleeding, intestinal obstruction, acute diverticulitis, acute pancreatitis, and acute cholecystitis. Multivariate Cox regression analysis done adjusting for confounders showed that renal failure, alcohol abuse, and peptic ulcer disease were associated with increased odds of 30-day readmission from GI-related causes.
GI manifestations of COVID-19 are not uncommon and remain an important cause of readmission. Targeted interventions addressing the modifiable predictors of readmission identified will be beneficial in reducing the burden on already limited healthcare resources.
2019年冠状病毒病(COVID-19)大流行在美国导致了严重的死亡率和发病率。COVID-19的负担不仅限于呼吸道,还具有显著的肺外表现。我们决定研究初次COVID-19住院后30天再入院的胃肠道(GI)相关病因、预测因素及结局。
我们使用2020年的国家再入院数据库(NRD)来确定主要诊断为COVID-19的成人住院病例。在排除择期和创伤性入院后,我们确定了初次入院后30天内与GI相关的住院病例。我们确定了GI相关再入院的主要原因以及这些住院病例的结局。我们使用多变量Cox回归分析来确定再入院的独立预测因素。
在2020年NRD数据库中,1,024,492例主要诊断为COVID-19的初次住院病例中,644,903例被纳入30天再入院研究。其中,3276例(0.5%)在30天内因主要的GI病因再次入院。我们在本研究中确定的再入院的前五大原因是GI出血、肠梗阻、急性憩室炎、急性胰腺炎和急性胆囊炎。在对混杂因素进行调整后进行的多变量Cox回归分析表明,肾衰竭、酗酒和消化性溃疡疾病与GI相关病因导致的30天再入院几率增加有关。
COVID-19的GI表现并不罕见,仍然是再入院的重要原因。针对已确定的可改变的再入院预测因素进行有针对性的干预,将有助于减轻本就有限的医疗资源的负担。